$0.14
arrow_drop_down7.81%Key Stats | |
---|---|
Open | $0.15 |
Prev. Close | $0.16 |
EPS | -139.08 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $16.16M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.14 | 0.15 |
52 Week Range | 0.12 | 5.50 |
Ratios | |
---|---|
EPS | -139.08 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency
Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication
Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering - GlobeNewswire
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket - Mainz Biomed ... - Benzinga